Jeremy Schafer Comments in Specialty Pharmacy News on Overcoming Costs for Gene Therapy
Jeremy Schafer, director of Precision’s Payer Access Solutions, offers insights into combating the risk and exposures of gene therapy. (more…)
Jeremy Schafer Address Payer Concerns on Dermira’s Acne Treatment in BioPharma
Jeremy Schafer, director of Precision’s Payer Access Solutions, weighs in on the concern of payer coverage for Dermira’s acne topical treatment. (more…)
Digital Biomarkers Becoming Integral to Precision Medicine
In a new commentary for Pharmaceutical Market Europe, Precision for Value’s Austin Speier, VP, Emerging Technology, examines the promise and advantages of integrating digital biomarkers into precision medicine. (more…)
PHE Expert Shafrin: Make Real-World Evidence the New Gold Standard
In an in-depth commentary for Pharmaceutical Market Europe, senior economist Jason Shafrin argues for real-world evidence (RWE) to become the “gold standard” of scientific evidence and heath technology assessments. (more…)
Precision Biomarker Data Management Expansion Detailed in GenomeWeb
In its weekly digest, GenomeWeb reports on Precision for Medicine’s expansion of biomarker data management and translational informatics services. (more…)